Contact Us

BUSINESS NEWS

Accropeutics Inc. Announces U.S. FDA Clearance of IND Application for RIPK2 Inhibitor AC-101

Dec 18, 2024

Company to conduct a Phase II multi-regional clinical trial (MRCT) for the treatment of Ulcerative Colitis (UC)

Keywords to understand China: The 3rd plenum

Dec 18, 2024

BEIJING,Dec. 13,2024--This is a report from China.org.cn:   Einar Tangen is a senior fellow at Taihe Institute. In this video,he offers an explanation of the key ideas pu

Mining gold of music: eternal passion of Chinese 99-year-old conductor

Dec 18, 2024

BEIJING,Dec. 13,2024-- A report from People\'s Daily: In July this year,the Shanghai Oriental Art Center (SHOAC) Citizens\' Concert celebrated its 18th anniversary. As the curtain rose,Chinese conduct

"25 Years of the Lotus Bond: A Tale of Unity and Progress" A five-part documentary marking the anniversary of Macao's return to China

Dec 18, 2024

BEIJING,Dec. 14,2024-- Twenty-five years after its return to China,Macao is thriving. To celebrate the anniversary of the historic event,CCTV4 has produced a five-part documentary,"25 Years of th

Global Times: Xi hears work report from HKSAR chief executive

Dec 18, 2024

BEIJING,Dec. 13,2024 President Xi Jinping on Friday said the central authorities fully support Hong Kong in aligning with national strategies and fostering new momentum and advantages for economic dev

Anviz Officially Launches OSDP-Enabled Access Control Solution

Dec 18, 2024

FREMONT,Calif.,Dec. 14,2024-- Anviz (a business unit of Xthings Group,Inc.) has officially launched an OSDP (Open Supervisory Device Protocol)-enabled access control solution. Our goal is simple: impr

1 ... 164 165 166 167 168 169 170 ... 347